Evaluating GenMol as a Generalist Foundation Model for Molecular Generation

Table of Contents
- SAFE Overview
- Lead Optimization
- Comparing SAFE-GPT and GenMol for Drug Discovery Tasks
- Molecular Generation and Exploration of Chemical Space
SAFE Overview
- Description: The Sequential Attachment-based Fragment Embedding (SAFE) representation simplifies scaffold decoration, linker design, and motif extension tasks into sequence completion tasks, enabling intuitive, fragment-based molecular design.
- Key Points:
- Versatility: Well-suited for scaffold decoration, linker design, and motif extension tasks.
- Representation: Preserves molecular scaffolds and accommodates complex structures without intricate graph-based models.
Lead Optimization
- Description: Allows for dynamic replacement of molecular fragments for iterative design refinement and optimization.
- Example Output: The figure shows output where fragment library and QED-scoring oracle facilitate GenMol inference for guided optimization.
Comparing SAFE-GPT and GenMol for Drug Discovery Tasks
- SAFE-GPT:
- Built on autoregressive transformer architecture.
- Suitable for fragment-constrained tasks like scaffold decoration and linker design.
- Outperforms models like f-RAG and REINVENT in goal-directed lead optimization.
- GenMol:
- More flexible and unified framework for diverse drug discovery applications.
- Suitable for hit generation and lead optimization tasks without fine-tuning.
Molecular Generation and Exploration of Chemical Space
- Description: SAFE-GPT uses GPT architecture for sequential, autoregressive decoding, making it applicable to de novo and fragment-constrained molecule generation.
- Applications:
- SAFE-GPT: Ideal for motif extension and scaffold generation with strict fragment constraints.
- GenMol: Better suited for researchers needing a flexible framework for various drug discovery tasks.
Test GenMol as an NVIDIA NIM now or explore code examples on GitHub to learn more about using GenMol for goal-directed hit optimization, lead optimization, and more.